Literature DB >> 15755741

Eap45 in mammalian ESCRT-II binds ubiquitin via a phosphoinositide-interacting GLUE domain.

Thomas Slagsvold1, Rein Aasland, Satoshi Hirano, Kristi G Bache, Camilla Raiborg, Daniel Trambaiolo, Soichi Wakatsuki, Harald Stenmark.   

Abstract

Ubiquitination serves as a key sorting signal in the lysosomal degradation of endocytosed receptors through the ability of ubiquitinated membrane proteins to be recognized and sorted by ubiquitin-binding proteins along the endocytic route. The ESCRT-II complex in yeast contains one such protein, Vps36, which harbors a ubiquitin-binding NZF domain and is required for vacuolar sorting of ubiquitinated membrane proteins. Surprisingly, the presumptive mammalian ortholog Eap45 lacks the ubiquitin-binding module of Vps36, and it is thus not clear whether mammalian ESCRT-II functions to bind ubiquitinated cargo. In this paper, we provide evidence that Eap45 contains a novel ubiquitin-binding domain, GLUE (GRAM-like ubiquitin-binding in Eap45), which binds ubiquitin with similar affinity and specificity as other ubiquitin-binding domains. The GLUE domain shares similarities in its primary and predicted secondary structures to phosphoinositide-binding GRAM and PH domains. Accordingly, we find that Eap45 binds to a subset of 3-phosphoinositides, suggesting that ubiquitin recognition could be coordinated with phosphoinositide binding. Furthermore, we show that Eap45 colocalizes with ubiquitinated proteins on late endosomes. These results are consistent with a role for Eap45 in endosomal sorting of ubiquitinated cargo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15755741     DOI: 10.1074/jbc.M501510200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

Review 1.  Shaping development with ESCRTs.

Authors:  Tor Erik Rusten; Thomas Vaccari; Harald Stenmark
Journal:  Nat Cell Biol       Date:  2011-12-22       Impact factor: 28.824

2.  Vesicle formation within endosomes: An ESCRT marks the spot.

Authors:  Jonathan R Mayers; Anjon Audhya
Journal:  Commun Integr Biol       Date:  2012-01-01

Review 3.  The ESCRT complexes.

Authors:  James H Hurley
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-07-23       Impact factor: 8.250

4.  WD40 repeat propellers define a ubiquitin-binding domain that regulates turnover of F box proteins.

Authors:  Natasha Pashkova; Lokesh Gakhar; Stanley C Winistorfer; Liping Yu; S Ramaswamy; Robert C Piper
Journal:  Mol Cell       Date:  2010-11-12       Impact factor: 17.970

5.  Human ESCRT-II complex and its role in human immunodeficiency virus type 1 release.

Authors:  Charles Langelier; Uta K von Schwedler; Robert D Fisher; Ivana De Domenico; Paul L White; Christopher P Hill; Jerry Kaplan; Diane Ward; Wesley I Sundquist
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

6.  Structural basis for endosomal targeting by the Bro1 domain.

Authors:  Jaewon Kim; Sujatha Sitaraman; Aitor Hierro; Bridgette M Beach; Greg Odorizzi; James H Hurley
Journal:  Dev Cell       Date:  2005-06       Impact factor: 12.270

7.  Structural and functional organization of the ESCRT-I trafficking complex.

Authors:  Michael S Kostelansky; Ji Sun; Sangho Lee; Jaewon Kim; Rodolfo Ghirlando; Aitor Hierro; Scott D Emr; James H Hurley
Journal:  Cell       Date:  2006-04-07       Impact factor: 41.582

Review 8.  The ESCRT complexes: structure and mechanism of a membrane-trafficking network.

Authors:  James H Hurley; Scott D Emr
Journal:  Annu Rev Biophys Biomol Struct       Date:  2006

9.  Ubiquitin binds to and regulates a subset of SH3 domains.

Authors:  Svetoslava D Stamenova; Michael E French; Yuan He; Smitha A Francis; Zachary B Kramer; Linda Hicke
Journal:  Mol Cell       Date:  2007-01-26       Impact factor: 17.970

10.  The RNA-binding complex ESCRT-II in Xenopus laevis eggs recognizes purine-rich sequences through its subunit, Vps25.

Authors:  Amy B Emerman; Michael D Blower
Journal:  J Biol Chem       Date:  2018-06-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.